Myeloma Minute: Boosting power, safety of immunotherapies


| INNOVATION | Latest Research


Promising New Methods for Ramping Up the Power, Safety of Immunotherapies

Two new studies illustrate how CAR T-cell therapies might be made safer and more effective in the future. Clinical trials are needed, says IMF Chairman Dr. Brian G.M. Durie, but these findings are very promising. Also, some guidance for people living with myeloma to avoid risks posed by the summer sun.


| ACTION | Win a Vacation


A 10-Day Luxury Hawaiian Oasis Is a Winning Raffle Ticket Away

The IMF is hosting a raffle for you to win a 10-day stay at the Villa Ono Oasis in Hawaii. The dates of this paradise vacation are March 16-26, 2020. The winners of this luxury package will receive:

  • A 10-day stay at the Villa Ono Oasis
  • Business-class Airfare for Two on American Airlines to Kailua-Kona, HI
  • A Dolphin Swim Adventure for Two
  • A Manta Ray Night Snorkel for Two
  • A Scuba Instruction Package for Two

Only 1000 raffle tickets will be sold @ $50 each: Tickets are selling fast. You can either visit the link below, or contact the IMF’s Karla Lemus at 1-800-452-CURE (2873) to purchase your ticket today. All proceeds will benefit International Myeloma Foundation Research and Programs.


| EDUCATION | Seminar


| INNOVATION | Clinical Trial


Register Now for the IMF Patient & Family Seminar in Charlotte, North Carolina
Learn More About the OCEAN Clinical Trial with This Fact Sheet

On September 6-7, 2019, the IMF will host a Patient & Family Seminar at the Westin Charlotte (601 S. College St.) in Charlotte, NC. Choose between two registration packages—either attend Friday’s half-day session and the all-day session Saturday, or attend the Saturday session only. Connect with other patients and caregivers. Together, we can learn, build community, and share our stories.

Melflufen is a new type of cancer therapy, a “peptide-conjugated alkylator” that rapidly delivers a toxic drug payload into myeloma cells, resulting in myeloma cell death. It is being studied as part of the international OCEAN Clinical Trial. Download details of this trial at the link below.

Register Now Button.png




Frank Caliendo Headlines the 4th Annual Laughs 4 Life Comedy Benefit

For the fourth year in a row, multiple myeloma patient Kent Oliver organizes the Laughs 4 Life Comedy Benefit. Laughs 4 Life will take place on Friday, August 2, 2019 at 7:30 p.m. CST at the historic Saenger Theater in downtown Hattiesburg, Mississippi. The night’s performers are headliner Frank Caliendo with opening act Keith Alberstadt. A portion of the proceeds of this event will benefit the International Myeloma Foundation.


| INNOVATION | Research Grants


Calling All Researchers: Submit Your Grant Applications

The Brian D. Novis Research Grants honor the IMF’s founder Brian Novis, who succumbed to multiple myeloma in July of 1992. The grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The 2020 grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. The deadline for applications is Thursday, August 1, 2019.


| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series



Search the Myeloma Matrix 2.0

Join the conversation about myeloma on the Smart Patients Message Board

Clinical Trial Fact Sheets

OCEAN Trial (Now Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

August 2, 2019
Laughs for Life
Hattiesburg, MS

August 23-24, 2019
IMF Patient & Family Seminar
Los Angeles, CA

September 6, 2019
IMF Patient & Family Seminar
Charlotte, NC

September 7, 2019
Wine Tasting & Tour
Richmond, VA

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Celgene Corporation, Genentech, and Takeda Oncology

We also thank individuals like you for your continued support!

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.